Therapy-related Acute Myeloid Leukemia Diagnosed at Postmortem in a Long-term Survivor of Advanced Hepatocellular Carcinoma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Acute myeloid leukemia (AML) is a common hematologic malignancy with high mortality and a short survival period in adults. About 10% of these cases, called therapy-related AML, are reported to be the consequence of chemotherapy or radiotherapy of previous malignancy. In a clinical setting, this is usually diagnosed by peripheral blood smear or bone marrow biopsy by assessing the proportion of blasts. However, postmortem blood samples are not suitable for smear analysis because of hemolysis. Therefore, ancillary tests for identifying leukemic infiltration or related molecular change can provide an alternative diagnostic clue for AML. The deceased had been treated for three years for a combined type of hepatocellular carcinoma with multiple pulmonary metastases. Treatments included the resections of primary and metastatic tumors, chemotherapy, and radiotherapy, which prevented further progression of his cancer. One year after the last treatment, he suddenly collapsed without any specific symptoms and shortly died. The microscopic examination of the autopsy samples revealed extensive extramedullary infiltration of leukemia, which was confirmed as an AML by a series of ancillary immunohistochemical staining. This case illustrates both the importance of careful hematologic observation in cancer survivors and the necessity of a detailed medical diagnosis in a medicolegal autopsy.
Abstract
Acute myeloid leukemia (AML) is a common hematologic malignancy with high mortality and a short survival period in adults. About 10% of these cases, called therapy-related AML, are reported to be the consequence of chemotherapy or radiotherapy of previous malignancy. In a clinical setting, this is usually diagnosed by peripheral blood smear or bone marrow biopsy by assessing the proportion of blasts. However, postmortem blood samples are not suitable for smear analysis because of hemolysis. Therefore, ancillary tests for identifying leukemic infiltration or related molecular change can provide an alternative diagnostic clue for AML. The deceased had been treated for three years for a combined type of hepatocellular carcinoma with multiple pulmonary metastases. Treatments included the resections of primary and metastatic tumors, chemotherapy, and radiotherapy, which prevented further progression of his cancer. One year after the last treatment, he suddenly collapsed without any specific symptoms and shortly died. The microscopic examination of the autopsy samples revealed extensive extramedullary infiltration of leukemia, which was confirmed as an AML by a series of ancillary immunohistochemical staining. This case illustrates both the importance of careful hematologic observation in cancer survivors and the necessity of a detailed medical diagnosis in a medicolegal autopsy.
참고문헌 (18)
- Shallis RM, "Epidemiology of acute myeloid leukemia : recent progress and enduring challenges", Blood Rev, 36, pp.70~87 (2019)
- De Kouchkovsky I, "Acute myeloid leukemia:a comprehensive review and 2016 update", Blood Cancer J, 6, pp.e441~ (2016)
- Hahn A, "Early mortality in acute myeloid leukemia", Leuk Res, 39, pp.505~509 (2015)
- Granfeldt Ostgard LS, "Epidemiology and clinical significance of secondary and therapyrelated acute myeloid leukemia : a national population-based cohort study", J Clin Oncol, 33, pp.3641~3649 (2015)
- Higgins A, "Genetic and genomic landscape of secondary and therapy-related acute myeloid leukemia", Genes(Basel), 11, pp.749~ (2020)
- Kayser S, "The impact of therapyrelated acute myeloid leukemia(AML)on outcome in 2853 adult patients with newly diagnosed AML", Blood, 117, pp.2137~2145 (2011)
- Santo AE, "Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia", Oncol Lett, 12, pp.262~268 (2016)
- Ornstein MC, "Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia", Am J Hematol, 89, pp.168~173 (2014)
- Van de Louw A, "Autopsy findings in patients with acute myeloid leukemia and non-Hodgkin lymphoma in the modern era : a focus on lung pathology and acute respiratory failure", Ann Hematol, 98, pp.119~129 (2019)
- Dokgoz H, "Comparison of morphological changes in white blood cells after death and in vitro storage of blood for the estimation of postmortem interval", Forensic Sci Int, 124, pp.25~31 (2001)
- Berens-Riha N, "Comparison of different methods for delayed post-mortem diagnosis of falciparum malaria", Malar J, 8, pp.244~ (2009)
- Cecchetto G, "Back to the future: Part 1. The medico-legal autopsy from ancient civilization to the postgenomic era", Int J Legal Med, 131, pp.1069~1083 (2017)
- Uchino K, "Hepatocellular carcinoma with extrahepatic metastasis : clinical features and prognostic factors", Cancer, 117, pp.4475~4483 (2011)
- Dierksen J, "Clinicopathologic findings of hematological malignancy : a retrospective autopsy study", Ann Clin Lab Sci, 45, pp.565~573 (2015)
- Bewersdorf JP, "Hyperleukocytosis and leukostasis in acute myeloid leukemia : can a better understanding of the underlying molecular pathophysiology lead to novel treatments", Cells, 9, pp.2310~ (2020)
- Ganzel C, "Hyperleukocytosis, leukostasis and leukapheresis: practice management", Blood Rev, 26, pp.117~122 (2012)
- Ali AM, "Leukostasis in adult acute hyperleukocytic leukemia : a clinician's digest", Hematol Oncol, 34, pp.69~78 (2016)
- Pryds K, "Fatal right-sided heart failure due to leukostasis in a patient with leukemic transformation of myelodysplastic syndrome", Clin Case Rep, 7, pp.115~119 (2019)